Fujii N - Search Results

1

Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain.

Fujii N, Mallari JP, Hansell EJ, Mackey Z, Doyle P, Zhou YM, Gut J, Rosenthal PJ, McKerrow JH, Guy RK. Fujii N, et al. Bioorg Med Chem Lett. 2005 Jan 3;15(1):121-3. doi: 10.1016/j.bmcl.2004.10.023. Bioorg Med Chem Lett. 2005. PMID: 15582423

2

Investigation of the PDZ domain ligand binding site using chemically modified peptides.

Novak KA, Fujii N, Guy RK. Novak KA, et al. Among authors: fujii n. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2471-4. doi: 10.1016/s0960-894x(02)00345-1. Bioorg Med Chem Lett. 2002. PMID: 12161160

3

Role of electrostatic interactions in PDZ domain ligand recognition.

Harris BZ, Lau FW, Fujii N, Guy RK, Lim WA. Harris BZ, et al. Among authors: fujii n. Biochemistry. 2003 Mar 18;42(10):2797-805. doi: 10.1021/bi027061p. Biochemistry. 2003. PMID: 12627945

4

A selective irreversible inhibitor targeting a PDZ protein interaction domain.

Fujii N, Haresco JJ, Novak KA, Stokoe D, Kuntz ID, Guy RK. Fujii N, et al. J Am Chem Soc. 2003 Oct 8;125(40):12074-5. doi: 10.1021/ja035540l. J Am Chem Soc. 2003. PMID: 14518976

5

A novel protein crosslinking reagent for the determination of moderate resolution protein structures by mass spectrometry (MS3-D).

Fujii N, Jacobsen RB, Wood NL, Schoeniger JS, Guy RK. Fujii N, et al. Bioorg Med Chem Lett. 2004 Jan 19;14(2):427-9. doi: 10.1016/j.bmcl.2003.10.043. Bioorg Med Chem Lett. 2004. PMID: 14698174

6

Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions.

Fujii N, Haresco JJ, Novak KA, Gage RM, Pedemonte N, Stokoe D, Kuntz ID, Guy RK. Fujii N, et al. Bioorg Med Chem Lett. 2007 Jan 15;17(2):549-52. doi: 10.1016/j.bmcl.2006.10.006. Epub 2006 Oct 6. Bioorg Med Chem Lett. 2007. PMID: 17055267

7

Design of a selective chemical probe for class I PDZ domains.

Fujii N, Shelat A, Hall RA, Guy RK. Fujii N, et al. Bioorg Med Chem Lett. 2007 Jan 15;17(2):546-8. doi: 10.1016/j.bmcl.2006.10.027. Epub 2006 Oct 17. Bioorg Med Chem Lett. 2007. PMID: 17074480

8

An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth.

Fujii N, You L, Xu Z, Uematsu K, Shan J, He B, Mikami I, Edmondson LR, Neale G, Zheng J, Guy RK, Jablons DM. Fujii N, et al. Cancer Res. 2007 Jan 15;67(2):573-9. doi: 10.1158/0008-5472.CAN-06-2726. Cancer Res. 2007. PMID: 17234765

9

Partial acetylation of lysine residues improves intraprotein cross-linking.

Guo X, Bandyopadhyay P, Schilling B, Young MM, Fujii N, Aynechi T, Guy RK, Kuntz ID, Gibson BW. Guo X, et al. Among authors: fujii n. Anal Chem. 2008 Feb 15;80(4):951-60. doi: 10.1021/ac701636w. Epub 2008 Jan 18. Anal Chem. 2008. PMID: 18201069

10

A phenotypic screen with Trypanosoma brucei for discovering small molecules that target the SLiM-binding pocket of proliferating cell nuclear antigen orthologs.

Actis M, Fujii N, Mackey ZB. Actis M, et al. Among authors: fujii n. Chem Biol Drug Des. 2024 Jan;103(1):e14361. doi: 10.1111/cbdd.14361. Epub 2023 Sep 28. Chem Biol Drug Des. 2024. PMID: 37767622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,117 results

Search Page

Filters